These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 9289653
1. Detection of Lyme disease after OspA vaccine. Schutzer SE, Luan J, Coyle PK. N Engl J Med; 1997 Sep 11; 337(11):794-5. PubMed ID: 9289653 [No Abstract] [Full Text] [Related]
2. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination. Molloy PJ, Berardi VP, Persing DH, Sigal LH. Clin Infect Dis; 2000 Jul 11; 31(1):42-7. PubMed ID: 10913394 [Abstract] [Full Text] [Related]
3. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, Krause DS. N Engl J Med; 1998 Jul 23; 339(4):209-15. PubMed ID: 9673298 [Abstract] [Full Text] [Related]
4. Immunization against Lyme disease--an important first step. Steigbigel RT, Benach JL. N Engl J Med; 1998 Jul 23; 339(4):263-4. PubMed ID: 9673306 [No Abstract] [Full Text] [Related]
5. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis. Fawcett PT, Rose CD, Budd SM, Gibney KM. Clin Diagn Lab Immunol; 2001 Jan 23; 8(1):79-84. PubMed ID: 11139199 [Abstract] [Full Text] [Related]
6. A recombinant vaccine for Lyme disease. Wallich R, Kramer MD, Simon MM. Behring Inst Mitt; 1994 Dec 23; (95):106-8. PubMed ID: 7755503 [Abstract] [Full Text] [Related]
7. Studies on OspA: a source of new paradigms in Lyme disease research. Philipp MT. Trends Microbiol; 1998 Feb 23; 6(2):44-7. PubMed ID: 9507636 [No Abstract] [Full Text] [Related]
8. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease. Wallich R, Siebers A, Jahraus O, Brenner C, Stehle T, Simon MM. Infect Immun; 2001 Apr 23; 69(4):2130-6. PubMed ID: 11254567 [Abstract] [Full Text] [Related]
11. [Lyme borreliosis--vaccines in the "pipeline"]. Kramer M. MMW Fortschr Med; 1999 Jun 24; 141(25):52-3. PubMed ID: 10897909 [No Abstract] [Full Text] [Related]
12. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. Callister SM, Schell RF. J Infect Dis; 1994 Aug 24; 170(2):499-500. PubMed ID: 8035047 [No Abstract] [Full Text] [Related]
13. Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old. Beran J, De Clercq N, Dieussaert I, Van Hoecke C. Clin Infect Dis; 2000 Dec 24; 31(6):1504-7. PubMed ID: 11096024 [Abstract] [Full Text] [Related]
15. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease. Shanafelt MC, Anzola J, Soderberg C, Yssel H, Turck CW, Peltz G. J Immunol; 1992 Jan 01; 148(1):218-24. PubMed ID: 1370170 [Abstract] [Full Text] [Related]
17. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. Ding W, Huang X, Yang X, Dunn JJ, Luft BJ, Koide S, Lawson CL. J Mol Biol; 2000 Oct 06; 302(5):1153-64. PubMed ID: 11183781 [Abstract] [Full Text] [Related]
18. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Simon MM, Gern L, Hauser P, Zhong W, Nielsen PJ, Kramer MD, Brenner C, Wallich R. Eur J Immunol; 1996 Dec 06; 26(12):2831-40. PubMed ID: 8977275 [Abstract] [Full Text] [Related]
19. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Chen J, Field JA, Glickstein L, Molloy PJ, Huber BT, Steere AC. Arthritis Rheum; 1999 Sep 06; 42(9):1813-22. PubMed ID: 10513794 [Abstract] [Full Text] [Related]
20. Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice. Bockenstedt LK, Fikrig E, Barthold SW, Kantor FS, Flavell RA. J Immunol; 1993 Jul 15; 151(2):900-6. PubMed ID: 8335917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]